Wesana Health Holdings Inc. (WSNAF)
Wesana Health Holdings Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Chicago, IL, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $73,221. On trailing twelve-month figures it carries a trailing P/E of -0.07, a net margin of 0.0%. Its beta of -0.70 implies it has historically moved less than the broad market.
Wesana Health Holdings Inc. is a life sciences firm dedicated to advancing and providing psychedelic-based therapies, including psilocybin-enhanced psychotherapy, primarily targeting the treatment of traumatic brain injuries (TBI). The company focuses on pioneering scientifically validated compounds and therapeutic strategies. Its mission is to enable patients suffering from trauma-related neurological, psychological, and mental health conditions to achieve recovery. Wesana Health is headquartered in Chicago, Illinois.
Wesana Health Holdings Inc. is most often compared with the following Healthcare names: